The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. (Q51480854)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 September 2016

Language	Label	Description	Also known as
English	The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries.	scientific article published on 19 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27651526

The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27651526

0 references

0 references

psoriatic arthritis

1 reference

based on heuristic

inferred from title

Þorvarður Jón Löve

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Pil Højgaard

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Bente Glintborg

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Lars Erik Kristensen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Bjorn Gudbjornsson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Lene Dreyer

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

19 September 2016

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27651526

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

55

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2191-2199

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Psoriatic arthritis: current therapy and future approaches

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Adiponectin in cardiovascular inflammation and obesity

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and risk of incident psoriatic arthritis in US women

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and the risk of psoriatic arthritis: a population-based study.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Body weight, gender and response to TNF-α blockers in axial spondyloarthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Relationships between Adipose Tissue and Psoriasis, with or without Arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and C-reactive protein in various populations: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Obesity and Knee Osteoarthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Depression and anxiety among US adults: associations with body mass index.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

The association between chronic pain and obesity

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEW326

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEW326

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651526%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51480854&oldid=1503823282"